The membrane-anchored serine prostasin (CAP1/PRSS8) is essential for barrier acquisition of the interfollicular epidermis and for normal hair follicle development. Consequently, prostasin null mice die shortly after birth. Prostasin is found in two forms in the epidermis: a one-chain zymogen and a two-chain proteolytically active form, generated by matriptase-dependent activation site cleavage. Here we used gene editing to generate mice expressing only activation site cleavage-resistant (zymogen-locked) endogenous prostasin. Interestingly, these mutant mice displayed normal interfollicular epidermal development and postnatal survival, but had defects in whisker and pelage hair formation. These findings identify two distinct in vivo functions of epidermal prostasin: a function in the interfollicular epidermis, not requiring activation site cleavage, that can be mediated by the zymogen-locked version of prostasin and a proteolysis-dependent function of activated prostasin in hair follicles, dependent on zymogen conversion by matriptase.Prostasin (also known as channel-activating protease-1, CAP1, and PRSS8) is a glycosylphosphatidylinositol-anchored trypsin-like serine protease that is widely expressed in epithelial tissues, including both the interfollicular and the follicular compartments of the epidermis. Loss-of-function genetic studies in mice have uncovered critical functions of prostasin in both the formation of epidermal barrier formation and the formation of whiskers and pelage hair (1, 2). Prostasin is synthesized as an inactive proform (zymogen) that is converted to a catalytically active protease by a single endoproteolytic cleavage in the conserved activation cleavage site (3-6). Prostasin zymogen conversion in the epidermis requires the membraneactivated serine protease matriptase (7-9). This observation, combined with the observation that both matriptase-deficient and prostasin-deficient mice display identical epidermal phenotypes, led to the formulation of the hypothesis that prostasin exerts its functions in this tissue as part of a matriptase-prostasin cell surface zymogen activation cascade (8). Several observations made during the last decade suggest, however, that prostasin may also execute biological functions independent of its own proteolytic activity. For example, in a reconstituted Xenopus oocyte system, prostasin can activate the epithelial sodium channel (ENaC) by inducing proteolytic cleavage of its ␥ subunit to release an inhibitory domain. However, this activation, which can be inhibited by the broad-spectrum serine protease inhibitor, aprotinin, can also be efficiently executed by mutant prostasin variants that lack the catalytic histidine-aspartate-serine triad (10 -12). Likewise, catalytically inactive prostasin mutants can stimulate the activation of protease-activated receptor-2 in a reconstituted mammalian cell-based system (13). Strong support for a non-proteolytic function of prostasin in vivo has been gained from the observation that mis-expressed catalytically inactive pros...